Results 281 to 290 of about 233,740 (307)

Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes.

Journal of Experimental Medicine, 1993
Douglas T Fearon, J M Ahearn, L B Klickstein   +2 more
exaly  

CD19 AND CD22 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

2022
ENGELS BORIS, GUIMARAES CARLA PATRICIA PINTO, MILATOS STAVROS, PASTORE ALESSANDRO, ZHU XU   +4 more
openaire   +1 more source

Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice

Molecular Therapy, 2018
Michael C Jensen, Jeffrey S. Miller, Jakub Tolar   +2 more
exaly  

Diphtheria toxin-based anti-human CD19 immunotoxin for targeting human CD19+ tumors

Molecular Oncology, 2017
Christene A Huang, Zhirui Wang, Huiping Zhang   +2 more
exaly  

CHIMERIC ANTIGEN RECEPTORS TARGETING CD37 AND CD19

2021
openaire   +2 more sources

Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis

Cell
Lingying Ye, Hongjuan Lu, Xinyi Wan
exaly  

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

Molecular Therapy, 2017
Tanya Siddiqi, Nancy L Bartlett, Armin Ghobadi   +2 more
exaly  

BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 AND CD20

2016
CHEN YVONNE Y, ZAH EUGENIA, JENSEN MICHAEL C   +2 more
openaire   +9 more sources

CD19 as an attractive target for antibody-based therapy

MAbs, 2012
exaly  

CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies

Journal of Cellular and Molecular Medicine, 2016
Oliver Ottmann, Torsten Tonn, Winfried Wels   +2 more
exaly